http://web.archive.org/web/20130523131907id_/http://www.cnn.com:80/2013/02/22/health/breast-cancer-drug

-- a drug that presents a new way to knock out cancer cells was approved friday to treat patients with a certain type of late - stage metastatic breast cancer			1
the drug , referred to as @entity9 during clinical research , will now be known by the brand name @entity9 , the @entity7 said in its approval announcement			1
it 's a new therapy for women with @entity16 - positive breast cancer			1
@entity9 is a combination of the targeted drug trastuzumab -- better known by the brand name @entity20 -- and a powerful chemotherapy drug called @entity9			1
it 's designed to work when @entity20 alone can no longer keep cancer in check			2
@entity9 is too toxic to deliver directly into a patient 's bloodstream , like other chemotherapy drugs			1
the @entity20 part of the new drug homes in on cancer cells , sparing other healthy cells , and delivers @entity9 into the cell			1
" @entity9 delivers the drug to the cancer site to shrink the tumor , slow disease progression and prolong survival , " said dr. @entity33 , director of the @entity34 in the @entity7 's @entity35 , in a statement			1
the drug is the fourth approved to target the @entity16 protein			0
@entity44 , the company that developed the drug , is working to get it to patients " imminently , " said spokesman @entity48			2
" as soon as humanly possible , but within two weeks at the outside			0
" @entity9 will cost about $ 9,800 monthly , which @entity50 said is " similar to the cost of other treatment regimens in this line of therapy			2
" the estimated cost of a course of @entity9 -- 9Â½ months -- is about $ 94,000			2
but " we want to ensure that people who are eligible for this medicine have access to it , " @entity50 said			0
@entity44 plans to initiate patient assistance programs for the drug to help those who might not be able to afford it ; those without health insurance or those who have reached the lifetime limit set by their insurance companies may qualify to receive @entity9 for free			1
experimental drug offers new way to battle certain breast cancer breast cancer is the second leading cause of cancer - related deaths among women , according to the @entity81 and the @entity82			1
@entity16 is a protein involved in normal cell growth			0
it 's found in increased amounts on some types of cancer cells			1
in her2 - positive breast cancers , the increased amount of the protein contributes to cancer call growth and survival			2
nearly 20 % of breast cancers have increased amounts of @entity16			0
researchers announced the results of a large three - year clinical trial of @entity9 in june , saying they were optimistic about it			0
one significant benefit , according to lead study author dr. @entity98 of @entity99 , is the lack of significant side effects and a better quality of life for patients on the drug			0
patients participating in the trial , she said , were the first group for whom officials worried about fixing their hair for media interviews			0
it 's important to note , however , that @entity9 is not the same as @entity20 and could cause serious side effects including liver problems and heart problems such as congestive heart failure or even death			1
it also can cause life - threatening birth defects , meaning pregnant women should not take it			0
the @entity7 's approval of the drug comes with the requirement that the prescribing information comes with a boxed warning alerting patients about the possibility of these side effects			2
however , the potential risks may be acceptable to women who have no other options , said dr. @entity136 , deputy chief medical officer for the @entity137			0
@entity9 , known as an " antibody - drug conjugate , " represents " a completely new way " to treat @entity16 positive metastatic breast cancer , said dr. @entity141 , chief medical officer and head of global product development for @entity44			1
an antibody - drug conjugate is described by the company as " a new kind of targeted medicine that can attach to certain types of cells and deliver chemotherapy directly to them			0
" " we currently have more than 25 antibody - drug conjugates in our pipeline and hope this promising approach will help us deliver more medicines to fight other cancers in the future , " @entity141 said in a statement			0
@entity0 's @entity160 contributed to this report .			0

the drug , @entity9 , presents a new way to knock out cancer cells
it 's meant for some patients with a certain type of metastatic breast cancer
the drug should be available to patients within two weeks

@entity16:HER2
@entity33:Richard Pazdur
@entity0:CNN
@entity7:FDA
@entity34:Office of Hematology and Oncology Products
@entity9:Kadcyla
@entity20:Herceptin
@entity44:Genentech
@entity81:National Cancer Institute
@entity82:U.S. Centers for Disease Control and Prevention
@entity50:Willson
@entity99:Duke University
@entity98:Kimberly Blackwell
@entity35:Center for Drug Evaluation and Research
@entity137:American Cancer Society
@entity136:Len Lichtenfeld
@entity48:Susan Willson
@entity160:Miriam Falco
@entity141:Barron